今日肿瘤学最高分文献 - 2025-01-30

欢迎收听今日医学焦点！一项突破性研究关注于tarlatamab，这是一种针对小细胞肺癌患者的最新双特异性T细胞引导免疫疗法。DeLLphi-301试验显示，每两周一次的10mg剂量治疗能够带来持久反应和生存益处。然而，常见的副作用包括细胞因子释放综合征、发热、食欲下降等，通常在第一或第二次给药后出现，并可通过支持性护理管理。作为首款获批治疗小细胞肺癌的T细胞引导疗法，了解并管理这些副作用至关重要。下一期节目，我们将深入探讨这些发现及其对患者护理的影响。不要错过！

Episode metadata supplied by the publisher feed · Published Jan 30, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

今日肿瘤学最高分文献 - 2025-01-30

0:00 1:40

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of 萌喵读文献-肿瘤学?

This episode is 1 minute long.

When was this 萌喵读文献-肿瘤学 episode published?

This episode was published on January 30, 2025.

Can I download this 萌喵读文献-肿瘤学 episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!